C21 Investments Past Performance
How has C21 Investments performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CXXI has high quality earnings.
Growing Profit Margin: CXXI's current net profit margins (12.7%) are lower than last year (26.1%).
Past Earnings Growth Analysis
Earnings Trend: CXXI has become profitable over the past 5 years, growing earnings by 30.1% per year.
Accelerating Growth: CXXI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CXXI had negative earnings growth (-55%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (14.5%).
Return on Equity
High ROE: CXXI's Return on Equity (9.9%) is considered low.